Johnson & Johnson

The Food and Drug Administration strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine on Thursday due to the ongoing risk of rare but serious blood clots

Johnson & Johnson’s new CEO Joaquin Duato says in his first interview that AI in medicine will lead to innovations including real-time surgery decisions.

U.S. stock futures fell Wednesday, one day after the Dow and S&P 500 logged four-session winning streaks and the Nasdaq saw back-to-back gains.

Evidence suggests the J&J shot might have an edge in durability over Pfizer’s and Moderna’s vaccines.

Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.

Pfizer CEO Albert Bourla appeared on CNBC exactly two years after Covid was declared a pandemic by the WHO on March 11, 2020.

A pandemic-weary public wants to know two main things: Will BA.2 cause a second surge of cases, and will it put even more people in the hospital?

It’s an ETF looking to make you money while saving lives.

Moderna plunged more than 12%, the biggest decline in the S&P 500 as of midafternoon Monday.

Commodity, dividend and risk-focused exchange-traded funds are gaining traction alongside concerns around inflation, ETF Action’s Mike Akins says.

The only Johnson & Johnson facility making usable batches of the company’s Covid vaccine has temporarily halted its production, The New York Times reported.

Moderna applied for emergency approval of its Covid vaccine for 12- to 17-year-olds in June, but the FDA said its review wouldn’t be completed before January.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors

Hollywood agencies are using TikTok to find new talent and harnessing the skills these content creators possess to bolster the careers of already established clients.

“A stock market’s like any other market, if you get too much inventory, prices will plummet,” the “Mad Money” host said.

Market volatility will lead cash-rich companies to be more opportunistic on mergers and acquisitions in 2022, including Johnson & Johnson, according to its CFO.

These are the stocks posting the largest moves in midday trading.

While many of those firms might look to be in a dismal state, CNBC’s Jim Cramer encouraged buyers to watch the big picture.

U.S. stock futures dropped Tuesday, with the Nasdaq looking down 2%, one day after a stunning market turnaround.

U.S. stock futures dropped Tuesday, with the Nasdaq indicated down 2%, one day after a stunning market turnaround.